# Adagio Medical > Adagio Medical, Inc. is a Laguna Hills, California medical device company and an operating > subsidiary of Adagio Medical Holdings, Inc. (NASDAQ: ADGM). It develops catheter-based cardiac > ablation systems on its Ultra-Low Temperature Cryoablation (ULTC) platform and an emerging > Pulsed Field Cryoablation (PFCA) platform, for ventricular tachycardia, atrial fibrillation and > atrial flutter. Its CE-marked vCLAS Cryoablation System holds FDA Breakthrough Device > Designation and is under U.S. evaluation in the FULCRUM-VT pivotal IDE study. ## API surface Adagio Medical publishes **no public API**. As of 2026-09-06 there is no developer portal, no API reference, no OpenAPI/AsyncAPI/GraphQL/gRPC/WSDL contract, no SDK in any public package registry, no MCP server, no A2A agent card and no `/.well-known/` discovery document on any Adagio Medical host. The company sells regulated physical devices to hospitals and electrophysiology labs; software is embedded in the console and catheter systems, not offered as a developer product. The only `/api` namespace on the corporate site is the site's own Next.js internal route, which `robots.txt` disallows. Probe record: `well-known/adagiomedical-well-known.yml` ## Company - [Adagio Medical](https://adagiomedical.com/): Corporate site (region-gated: `/us` and `/eu`) - [About Adagio Medical](https://adagiomedical.com/us/about): Company, mission, leadership, board - [vCLAS Cryoablation System](https://adagiomedical.com/us/products-vclas): Flagship product - [Fundamentals of ULTA](https://adagiomedical.com/us/technology-ulta): Ultra-low temperature ablation technology - [Fundamentals of PFCA](https://adagiomedical.com/us/technology-pfca): Pulsed field cryoablation technology - [Clinical studies](https://adagiomedical.com/us/clinical-evidence-studies): FULCRUM-VT and other trials - [Investor relations](https://investors.adagiomedical.com/): Adagio Medical Holdings, Inc. (NASDAQ: ADGM) - [Careers](https://adagiomedical.com/us/careers) - [Contact](https://adagiomedical.com/us/contact) ## Security and legal - [Product Security](https://adagiomedical.com/us/product-security): Coordinated vulnerability disclosure policy. Report to `product_security@adagiomedical.com`; receipt confirmed within five business days. No bug bounty, no `/.well-known/security.txt`. - [Privacy Policy](https://adagiomedical.com/us/privacy-policy) - [Terms of Use](https://adagiomedical.com/us/terms-of-use) ## API Evangelist artifacts - [apis.yml](https://raw.githubusercontent.com/api-evangelist/adagiomedical/refs/heads/main/apis.yml) - [Vulnerability disclosure](https://raw.githubusercontent.com/api-evangelist/adagiomedical/refs/heads/main/security/adagiomedical-vulnerability-disclosure.yml) - [Domain security probe](https://raw.githubusercontent.com/api-evangelist/adagiomedical/refs/heads/main/security/adagiomedical-domain-security.yml) - [Well-known probe](https://raw.githubusercontent.com/api-evangelist/adagiomedical/refs/heads/main/well-known/adagiomedical-well-known.yml)